Jupiter Endovascular, Inc. announced that the full results of the SPIRARE II pivotal trial, evaluating the company’s Vert ...

Srinivas Attanti, MD, FACC Cardiologist and Interventional Cardiologist Citrus Cardiology Consultants, PLLC Florida ...

Real-world evidence comparing TCAR with TFCAS and CEA across surgical risk and symptom status and the role of the ENROUTE™ ...

A summary of four recent studies evaluating locoregional therapies for hepatocellular carcinoma and percutaneous ablation for ...

The FDA approved the PerQseal Elite vascular closure system for large-bore arterial procedures in the United States. The bioabsorbable, sutureless device is designed to close arteriotomies up to 26 F ...

News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.

News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.

News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.

News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.

News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.

News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.

News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.